About Unibio
Unibio is a Healthcare company based in Odense (Denmark) founded in 2001. It operates as an animal feed supplements are produced using proprietary fermentation technology. It operates on a Product-as-a-Service and Direct-to-Consumer (D2C) model in Healthcare and Agriculture sectors. Unibio has raised $30 million across 5 funding rounds from investors including European Union, Saudi Industrial Investment Group and West Hill Capital. Unibio offers products and services including Uniprotein® Aquaculture, Uniprotein® Livestock, Uniprotein® Pet Food, and Uniprotein® Human Nutrition. Its focus areas include Biotechnology, Sustainable Protein and Microbial Protein Production. Its legal entity is Unibio International PLC. Its competitors include Calysta, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Scalable protein production is pioneered by Unibio using advanced fermentation technology. Solutions are tailored for aquaculture, livestock, pet food, and human nutrition sectors. The focus is placed on planet-friendly methods to address global protein demand. Environmental challenges are tackled by reducing deforestation and overfishing. Innovation is driven to transform the protein industry across multiple applications. Food security is enhanced without compromising planetary resources. A commitment is made to sustainable and efficient protein production systems.
- Total Equity Funding$30M (USD)
in 5 rounds
- InvestorsEuropean Union
& 2 more
Products & Services of Unibio
Unibio offers a comprehensive portfolio of products and services, including Uniprotein® Aquaculture, Uniprotein® Livestock, Uniprotein® Pet Food, and Uniprotein® Human Nutrition.
Sustainable protein is provided for responsible aquaculture feed solutions.
Future-proof protein is offered for enhancing livestock feed nutrition.
Nutrient-packed, planet-friendly protein is developed for pet food products.
Healthy, sustainable protein is created for human nutrition applications.
Apps and channels of Unibio
its YouTube channel Unibio TV has 131 subscribers and 6 videos.
Videos from Unibio
The most watched videos on Unibio's YouTube channel, Unibio TV (131 subscribers). Click a video to play it here.
More on Unibio TV.
Funding Insights of Unibio
Unibio has successfully raised a total of $30M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30M
- Total Rounds 5
- First Round $2.83M
(Jan 2018)
- Investors Count 3
All 5 funding rounds of Unibio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | – | Series D | – | Saudi Industrial Investment Group | – |
| Jun 2021 | $15M | Series D | – | West Hill Capital | – |
| Aug 2019 | $15M | Series D | – | West Hill Capital | – |
| Nov 2018 | $2.68M | Grant | – | – | |
| Jan 2018 | $2.83M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Unibio
Unibio has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Saudi Industrial Investment Group and West Hill Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage venture capital investments are provided by West Hill Capital. | – | westhillcapital.co.uk | London, United Kingdom | |
Petrochemical infrastructure investments are managed by the fund. | 1996 | siig.com.sa | Riyadh, Saudi Arabia | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Unibio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Unibio
3 dated milestones of Unibio across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Unibio is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Series D,.
Competitors of Unibio
Unibio has 8 listed competitors in our database, 6 of them funded. They include Calysta, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| calysta.com | 2011 | Menlo Park, United States | $177.22M | 21 | Protein nutritional feeds for animals are produced via natural fermentation. | |
| univercellstech.com | 2020 | Nivelles, Belgium | – | 74 | Intensified biomanufacturing technologies for viral production are developed and manufactured. | |
| nirrin.tech | 2018 | Billerica, United States | $4.82M | 17 | Developer of sensor and integration technologies for continuous control and bioprocess automation | |
| pow.bio | 2019 | Berkeley, United States | $9.5M | – | Intelligent fermentation services for industrial and synthetic biology are provided. | |
| caladan.bio | 2023 | Brooklyn, United States | $5.11M | – | Modular bioreactors are developed for biotechnology research applications. | |
| biozeen.com | 2005 | Bengaluru, India | – | 194 | Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals. | |
| trelystech.com | 2012 | San Francisco, United States | $2.58M | – | Produces bio animal feed ingredients using methanogen bioconversion technology. | |
| dab.bio | 2012 | Delft, Netherlands | $2.23M | – | Technology solutions for accelerated fermentation of renewable feedstocks are provided. |
Detailed competitors of Unibio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Unibio
The website of Unibio (unibio.dk) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 66.5% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Unibio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Unibio
Complete news archive for Unibio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unibio
Unibio was founded in 2001 and raised its 1st funding round 17 years after it was founded.
Unibio is headquartered in Odense, Denmark.
Unibio is a funded company, having raised a total of $30M across 5 funding rounds to date. The company's 1st funding round was a Grant of $2.83M, raised on Jan 2018.
Scalable protein production is pioneered by Unibio using advanced fermentation technology. Solutions are tailored for aquaculture, livestock, pet food, and human nutrition sectors. The focus is placed on planet-friendly methods to address global protein demand. Environmental challenges are tackled by reducing deforestation and overfishing. Innovation is driven to transform the protein industry across multiple applications. Food security is enhanced without compromising planetary resources. A commitment is made to sustainable and efficient protein production systems.
Unibio's top competitors include Calysta, Univercells Tech and Nirrin Technologies.
Unibio offers Uniprotein® Aquaculture, Uniprotein® Livestock, Uniprotein® Pet Food, and Uniprotein® Human Nutrition.
Unibio has 3 investors. Key investors include European Union, Saudi Industrial Investment Group, and West Hill Capital.
Unibio operates through Unibio International Plc.